This Justification (J&A) opportunity from Department Of Health And Human Services was posted on September 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
PrisMax V3
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center is procuring one PrisMax V3 US Continuous Renal Replacement Therapy machine, one TherMax Blood Warmer, and one PrisMax Warmer Arm Kit for a total acquisition value of 32,868.25. This equipment is intended for the new Pediatric Intensive Care Unit to treat patients weighing 20 kilograms or more who have acute renal failure, fluid overload, or require therapeutic plasma exchange. The system supports multiple therapy modes, including CVVHDF, CVVHD, CVVH, and SCUF. This is a sole source acquisition conducted under FAR 13.106-1(b)(1) with Vantive as the sole proprietor. The justification for the sole source award is based on the need for clinical consistency and patient safety, as well as the requirement for the equipment to integrate with the hospital's existing CRIS electronic health record system. The procurement ensures standardization across the clinical center's existing fleet of five PrisMax machines. The place of performance is located in Bethesda, Maryland.
General Info
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
With the establishment of the new Pediatric Intensive Care Unit (PICU), the CC needs to add one PrisMax Continuous Renal Replacement Therapy (CRRT) machine to their existing fleet of 5 Prismax CRRT. The CC successfully integrated the PrisMax with the hospital’s EHR, CRIS in 2020.
PrisMax Systems are intended for:
- Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
- Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
- The TherMax Blood Warmer Accessory is indicated for warming returning blood flow.
DESCRIPTION OF THE SUPPLIES AND SERVICES REQUIRED, INCLUDING THE DELIVERY SCHEDULE AND/OR THE PERIOD OF PERFORMANCE and DOLLAR VALUE OF THE ACQUISITON.
Procurement is for:
- One (1) PrisMax V3 US
- One (1) TherMax Blood Warmer
- One (1) PrisMax Warmer Arm Kit
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
